drugset / Trial / NCT02670343

Phlebotomy Study of Testosterone Undecanoate

NCT02670343

Phase 1/2 Completed 8 enrolled Clarus Therapeutics, Inc.
NaSingle-groupOpen-labelBasic science

Summary

An open-label, single oral TU dose study was conducted in eight (8) hypogonadal men at a single study site. Each study participant received a single oral TU dose immediately prior to a standardized breakfast meal comprised of 800 to 1000 calories and approximately 30 g of fat. Blood samples were collected 30 minutes prior dose administration and at 0 pre-dose and post dose at the following hours post-dose; 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours.

Timeline

Start
2016-01
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Background Testosterone Undecanoate Small molecule 158 mg Oral

Indications